TEST UPDATE HIV-1/2 Ag/Ab Combo December 17, 2014 Porter Hospital Laboratory has introduced a new assay for HIV-1/2. The Alere Determine™ HIV–1/2 Ag/Ab Combo is an in vitro, visually read, qualitative immunoassay for the detection of Human Immunodeficiency Virus Type 1 (HIV-1) p24 antigen (Ag) and antibodies (Ab) to HIV Type1 and Type 2 (HIV-1 and HIV-2) in human serum, plasma, capillary (fingerstick) whole blood or venipuncture (venous) whole blood. It is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV-1 and HIV-2, including an acute HIV-1 infection, and may distinguish acute HIV-1 infection from established HIV-1 infection when the specimen is positive for HIV-1 p24 antigen and negative for antiHIV-1 and anti-HIV-2 antibodies. A Reactive result using Alere Determine™ HIV-1/2 Ag/Ab Combo suggests the presence of HIV-1 p24 antigen and/or antibodies to HIV-1 and/or HIV-2 in the sample. The Reactive result is interpreted as Preliminary Positive for HIV-1 p24 antigen and/or antibodies to HIV-1 and/or HIV-2. Alere Determine™ HIV-1/2 Ag/Ab Combo is intended as aid in the diagnosis of infection with HIV-1/2. AIDS-related conditions are clinical syndromes, and their diagnosis can only be established clinically. A Nonreactive result does not preclude the possibility of exposure to HIV or infection with HIV. All preliminary results reported as REACTIVE will be sent for confirmatory testing. Ordering specifics:
Test Name: Sample Requirements: Volume Required: Minimum Volume: Days Performed: Analytical Time: CPT Code: Price:
HIV COMBO Serum from Gel/Tiger Top 0.5 ml serum 0.2 ml. serum Daily Same Day and STAT for Exposures 86703 $131.00